Simple Prepregnant Prediction Rule for Recurrent Early-onset Hypertensive Disease in Pregnancy

被引:20
作者
Sep, Simone J. S. [1 ,2 ,3 ]
Smits, Luc J. M. [1 ]
Prins, Martin H. [1 ]
Spaanderman, Marc E. A. [4 ]
Peeters, Louis L. H. [2 ,3 ]
机构
[1] Maastricht Univ, Dept Epidemiol, Sch Publ Hlth & Primary Care Caphri, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Fac Med, Dept Obstet & Gynaecol, Univ Med Ctr Maastricht, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Fac Med, Res Inst Growth & Dev GROW, NL-6200 MD Maastricht, Netherlands
[4] Univ Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands
关键词
prediction; recurrence; preeclampsia; HELLP syndrome; ELEVATED LIVER-ENZYMES; SUBSEQUENT PREGNANCY; LOW PLATELETS; VALIDATION; HEMOLYSIS; OUTCOMES;
D O I
10.1177/1933719108324889
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: We aimed to develop a simple clinically useful prediction rule for early-onset recurrent preeclampsia and/or HELLP syndrome. Methods: Women with previous early-onset preeclampsia and/or HELLP, enrolled between 1996 and 2007, and a subsequent ongoing pregnancy were included. Prepregnant cardiovascular, metabolic, renal, and clotting parameters were evaluated as potential predictors for recurrent disease by logistic regression analysis. Results: Early-onset preeclampsia and/or HELLP recurred in 16 (9%) of 186 next pregnancies. The prediction model included high-density lipoprotein (mmol/L) and 24-hour urinary total protein excretion (mg/mmol creatinine). The receiver operating characteristic area was 0.77 (95% confidence interval: 0.68-0.87). Predictive sensitivity and specificity were 94% (69%-99%) and 53% (45%-60%), respectively. Nearly 50% of the women could be classified as having < 1% risk of recurrent early-onset disease. Conclusions: The prediction rule identified, with clinically relevant predictive capacity, those women at very low risk for recurrent early-onset disease.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 19 条
[1]  
[Anonymous], 2001, OBSTET GYNECOL, V98, P177
[2]   World Health Organization systematic review of screening tests for preeclampsia [J].
Conde-Agudelo, A ;
Villar, J ;
Lindheimer, M .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (06) :1367-1391
[3]  
Frusca T, 1996, ITAL J GYNAECOL OBST, V8, P94
[4]   The diagnostic odds ratio: a single indicator of test performance [J].
Glas, AS ;
Lijmer, JG ;
Prins, MH ;
Bonsel, GJ ;
Bossuyt, PMM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (11) :1129-1135
[5]  
Harlow FH, 2001, HYPERTENS PREGNANCY, V20, P57, DOI 10.3109/10641950109152642
[6]  
Longford NT, 2005, STAT SOC SCI PUBL P, P3
[7]  
Mello G, 2002, J Matern Fetal Neonatal Med, V11, P93, DOI 10.1080/713605463
[8]  
Morris J, 1998, J MATERN-FETAL INVES, V8, P82
[9]   Facts and recommendations about total homocysteine determinations: An expert opinion [J].
Refsum, H ;
Smith, AD ;
Ueland, PM ;
Nexo, E ;
Clarke, R ;
McPartlin, J ;
Johnston, C ;
Engbaek, F ;
Schneede, J ;
McPartlin, C ;
Scott, JM .
CLINICAL CHEMISTRY, 2004, 50 (01) :3-32
[10]  
Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5